In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

From 1990 to 2023, there was a decrease in both the number of births and in general and total fertility rates.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

Gazette's Gerry Dulac argued wide receiver George Pickens faces an uncertain future with the Pittsburgh Steelers. The post WR ...

As the UK government’s sustainable aviation fuel mandate begins to take effect, STEPHEN BRIDGEWATER FRAeS takes a deep dive ...

Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...

Progression-free survival in patients with EGFR-mutated locally advanced or metastatic NSCLC ... in the gefitinib group (hazard ratio [HR], 0.48; 95% CI, 0.36-0.63; P <.0001). Consistent results were ...

Detailed price information for Greenfire Resources Ltd (GFR-N) from The Globe and Mail including charting and trades.

Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results ...